PapersFlow Research Brief
Opioid Use Disorder Treatment
Research Guide
What is Opioid Use Disorder Treatment?
Opioid Use Disorder Treatment encompasses clinical guidelines, screening tools, medication-assisted therapies, and public health strategies aimed at managing addiction, reducing opioid misuse, preventing overdoses, and addressing chronic pain while minimizing long-term risks.
The field includes 63,697 works focused on opioid prescribing guidelines, chronic pain management, opioid overdose, addiction treatment, prescription opioids, mortality risk, substance use disorders, abuse and dependence, medication-assisted therapy, and the public health crisis associated with opioid misuse. Dowell et al. (2016) in "CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016" provide recommendations to improve safety and effectiveness of opioid therapy for chronic pain. Mattick et al. (2014) in "Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence" demonstrate buprenorphine's effectiveness in retaining patients in treatment and suppressing illicit opioid use.
Topic Hierarchy
Research Sub-Topics
Medication-Assisted Treatment for Opioid Use Disorder
Medication-Assisted Treatment (MAT) involves pharmacotherapies like methadone, buprenorphine, and naltrexone combined with behavioral therapy for opioid dependence. Researchers conduct clinical trials on efficacy, retention rates, and implementation barriers in diverse populations.
Opioid Overdose Prevention Strategies
This subtopic covers interventions like naloxone distribution, overdose education, and fentanyl test strips to reverse and prevent fatal overdoses. Researchers evaluate community-based programs, policy impacts, and epidemiology of overdose trends.
Chronic Non-Cancer Pain Management Guidelines
Guidelines address opioid prescribing for chronic pain, emphasizing risk stratification, multimodal therapy, and deprescribing protocols. Researchers assess guideline adherence, patient outcomes, and alternatives like non-pharmacological interventions.
Opioid Use Disorder Screening Instruments
Validated tools like the Drug Abuse Screening Test (DAST) and Opioid Risk Tool identify at-risk individuals in clinical and community settings. Researchers validate instruments across populations and integrate them into electronic health records.
Economic Burden of the Opioid Epidemic
Economic analyses quantify healthcare costs, lost productivity, and criminal justice expenses attributable to opioid misuse. Researchers model cost-effectiveness of interventions and forecast fiscal impacts of policy changes.
Why It Matters
Opioid Use Disorder Treatment directly addresses the U.S. opioid epidemic, where drug overdose deaths nearly tripled from 1999 to 2014, with 28,647 (60.9%) of 47,055 deaths in 2014 involving opioids, as reported by Rudd et al. (2016) in "Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015". Guidelines like "CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016" by Dowell, Haegerich, and Chou (2016) guide primary care clinicians on initiating opioids, selecting dosages, and assessing benefits versus risks for chronic noncancer pain, reducing misuse risks. Medication-assisted therapies, such as buprenorphine versus methadone evaluated by Mattick et al. (2014), retain patients in treatment at doses above 2 mg and suppress illicit use at 16 mg or greater, supporting addiction recovery in clinical settings. Screening tools like the CAGE questionnaire by Ewing (1984) and Drug Abuse Screening Test by Skinner (1982) enable early detection of substance use disorders, facilitating timely interventions in public health and primary care.
Reading Guide
Where to Start
"CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016" by Dowell, Haegerich, and Chou (2016) as it offers foundational recommendations for clinicians on safe opioid use in chronic pain, central to treatment practices.
Key Papers Explained
Dowell et al. (2016) in "CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016" establishes prescribing standards, complemented by Chou et al. (2009) in "Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain" which details assessment and monitoring protocols. Mattick et al. (2014) in "Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence" builds evidence for medication-assisted treatment options like buprenorphine. Rudd et al. (2016) in "Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015" quantifies epidemic scale, contextualizing guideline needs. Screening tools from Ewing (1984) "Detecting alcoholism. The CAGE questionnaire" and Skinner (1982) "The drug abuse screening test" support early intervention preceding these therapies.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Field centers on refining guidelines from Dowell et al. (2016) and Chou et al. (2009) amid ongoing overdose increases noted by Rudd et al. (2016), with emphasis on buprenorphine optimization per Mattick et al. (2014). No recent preprints or news available indicate stable focus on established interventions like medication-assisted therapy and screening.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | CDC Guideline for Prescribing Opioids for Chronic Pain—United ... | 2016 | JAMA | 5.1K | ✓ |
| 2 | The fifth edition of the addiction severity index | 1992 | Journal of Substance A... | 4.2K | ✓ |
| 3 | Respondent-Driven Sampling: A New Approach to the Study of Hid... | 1997 | Social Problems | 4.2K | ✕ |
| 4 | Detecting alcoholism. The CAGE questionnaire | 1984 | JAMA | 4.0K | ✕ |
| 5 | The drug abuse screening test | 1982 | Addictive Behaviors | 3.1K | ✕ |
| 6 | CDC Guideline for Prescribing Opioids for Chronic Pain — Unite... | 2016 | MMWR Recommendations a... | 2.6K | ✓ |
| 7 | The Economic Costs of Pain in the United States | 2012 | Journal of Pain | 2.3K | ✕ |
| 8 | Buprenorphine maintenance versus placebo or methadone maintena... | 2014 | Cochrane Database of S... | 2.2K | ✓ |
| 9 | Increases in Drug and Opioid-Involved Overdose Deaths — United... | 2016 | MMWR Morbidity and Mor... | 2.2K | ✓ |
| 10 | Clinical Guidelines for the Use of Chronic Opioid Therapy in C... | 2009 | Journal of Pain | 2.2K | ✓ |
Frequently Asked Questions
What recommendations does the CDC provide for prescribing opioids for chronic pain?
Dowell et al. (2016) in "CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016" recommend primary care clinicians determine when to initiate or continue opioids for chronic pain outside cancer treatment, select opioid types, manage dosages, conduct assessments, and mitigate risks. The guideline improves communication on benefits and risks, enhances pain treatment safety and effectiveness, and reduces long-term opioid therapy hazards. It addresses opioid selection, dosage, duration, follow-up, and discontinuation strategies.
How effective is buprenorphine compared to methadone for opioid dependence?
Mattick et al. (2014) in "Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence" found buprenorphine effective in retaining patients in treatment at doses above 2 mg and suppressing illicit opioid use at 16 mg or greater based on placebo-controlled trials. Compared to methadone, buprenorphine retains fewer people in treatment but shows similar suppression of illicit opioid use. These findings support buprenorphine as a viable maintenance therapy option.
What is the CAGE questionnaire used for in detecting alcoholism?
Ewing (1984) in "Detecting alcoholism. The CAGE questionnaire" describes four questions focusing on Cutting down, Annoyance by criticism, Guilty feeling, and Eye-openers to diagnose alcoholism. The acronym aids physician recall during clinical interviews. The questions prove useful for identifying alcoholism through patient responses.
What trends in opioid overdose deaths occurred from 2010 to 2015?
Rudd et al. (2016) in "Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015" report drug overdose deaths nearly tripled from 1999-2014, with 60.9% of 47,055 deaths in 2014 involving opioids. Illicit opioids contributed to the rise. The U.S. opioid epidemic continued during this period.
What is Respondent-Driven Sampling used for in hidden populations?
Heckathorn (1997) in "Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations" introduces a method for populations without sampling frames where membership acknowledgment is threatening, such as substance users. It overcomes low response rates and lack of candor in standard probability sampling. The approach relies on peer-driven recruitment for reliable data.
What guidelines exist for chronic opioid therapy in noncancer pain?
Chou et al. (2009) in "Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain" provide clinical guidance on using long-term opioids. The guidelines address assessment, initiation, monitoring, and discontinuation to balance benefits and risks. They support informed decision-making in pain management.
Open Research Questions
- ? How can opioid prescribing guidelines be optimized to further reduce overdose risks while maintaining effective chronic pain control?
- ? What factors explain why buprenorphine retains fewer patients than methadone despite similar suppression of illicit opioid use?
- ? How effective are respondent-driven sampling methods in accurately estimating prevalence of opioid use disorder in hidden populations?
- ? What improvements to screening tools like CAGE and DAST would enhance early detection of opioid use disorders?
- ? How do economic costs of pain influence access to non-opioid treatment alternatives for opioid use disorder patients?
Recent Trends
Opioid overdose deaths rose sharply, nearly tripling from 1999-2014 with 60.9% of 47,055 deaths in 2014 opioid-involved, per Rudd et al.
2016No growth rate available for 63,697 works; no recent preprints or news reported.
Research Opioid Use Disorder Treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Opioid Use Disorder Treatment with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers